| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.155 | 1.521 | 0 | 0 | 0 | 388.357 | 255.849 | 122.056 | 87.635 | 105.873 |
| Total Income - EUR | 8.155 | 1.521 | 0 | 0 | 0 | 388.306 | 255.474 | 121.560 | 87.635 | 105.873 |
| Total Expenses - EUR | 216 | 140 | 26 | 0 | 24 | 121.915 | 202.976 | 71.815 | 51.750 | 49.742 |
| Gross Profit/Loss - EUR | 7.939 | 1.381 | -26 | 0 | -24 | 266.391 | 52.498 | 49.745 | 35.885 | 56.131 |
| Net Profit/Loss - EUR | 7.694 | 1.335 | -26 | 0 | -24 | 261.186 | 49.974 | 48.662 | 35.123 | 54.132 |
| Employees | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biosilmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16 | 16 | 16 | 15 | 15 | 20.544 | 34.051 | 46.755 | 46.613 | 46.352 |
| Current Assets | 8.199 | 9.505 | 9.319 | 9.148 | 261.502 | 363.476 | 343.176 | 400.053 | 398.228 | 430.553 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 1.470 | 8.107 | 16.770 | 23.416 | 4.593 |
| Receivables | 8.171 | 1.521 | 1.495 | 1.468 | 253.974 | 349.220 | 324.215 | 382.566 | 374.463 | 419.238 |
| Cash | 28 | 7.985 | 7.823 | 7.680 | 7.528 | 12.785 | 10.853 | 717 | 350 | 6.723 |
| Shareholders Funds | 7.739 | 9.005 | 8.826 | 8.664 | 8.473 | 269.499 | 324.888 | 337.969 | 372.067 | 398.963 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 476 | 517 | 508 | 499 | 253.044 | 114.520 | 52.339 | 108.838 | 72.774 | 77.943 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Biosilmed Srl